Flo Health Becomes First Femtech Unicorn

London-based Flo Health, a leading femtech company, has raised over €200 million in Series C funding from General Atlantic. This investment pushes Flo’s valuation beyond $1 billion, making it the first purely digital women’s health app to achieve unicorn status.

• Comprehensive Women’s Health: Flo supports women through every stage of their health journey—from menstruation to menopause. With a team of over 120 doctors and health experts, the app provides cycle and ovulation tracking, symptom monitoring, and tailored health insights.

• Enhanced Features: Flo offers daily visual content, expert tips, and access to a private digital community, aimed at enhancing user understanding and management of health.

• Future Growth Plans: With General Atlantic’s investment, Flo plans to expand into areas such as perimenopause and menopause, and enhance its technology and services. The company will also focus on increasing its R&D team and pursuing global expansion.

• Remarkable Growth: Over eight years, Flo has grown significantly, boasting nearly 70 million monthly active users and close to 5 million paid subscribers as of June 2024.

• Leader Insight: Dmitry Gurski, CEO of Flo Health, emphasizes the importance of reaching unicorn status and the company’s commitment to advancing women’s health globally.

This funding round highlights Flo Health’s significant growth and its ongoing commitment to improving women’s health through innovative digital solutions.